PharmaMedic Announces Expanded Medical Affairs Solutions to Boost Branded Sales from Existing Generic Portfolios
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
The global demand for generic pharmaceuticals is growing, but manufacturers face significant hurdles. Regulatory complexity, market entry barriers, and the need for product differentiation require strategic thinking. At the same time, manufacturers must maintain tight control over costs to succeed.
A High Court judgment on a judicial review brought by the British Generic Manufacturers Association (BGMA) has dismissed the organisation’s claim that it was unfairly excluded from talks on the next Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).